MedPath

Effectiveness of oral elemental nutritional supplement for patients with unresectable pancreatic cancer; a prospective cohort study

Phase 3
Conditions
unresectable pancreatic cancer
Registration Number
JPRN-UMIN000025967
Lead Sponsor
Department of Gastroenterology, Japanese Red Cross Okayama Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1.severe complication 2.disability of oral intake 3.Inflammatory bowel disease 4.ECOG scale of performance status 3-4

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum albumin at 3 months compare with historical control
Secondary Outcome Measures
NameTimeMethod
compare with historical control below 1.serum total protein at 3 months 2.how long days patients could receive chemotherapy 3.over all survival 4.progression free survival 5.body weight at 3 month 6.how long days patients could drink elemental nutritional supplement
© Copyright 2025. All Rights Reserved by MedPath